Loading presentation...

Present Remotely

Send the link below via email or IM


Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.


Stem Cell Biology Seminar Summary: Stem Cell Therapy for Human Neurodegenerative Disorders (2004)

A summary on the following review paper: http://celleng.sjtu.edu.cn/pic/xq19.pdf

Satya Yerrabolu

on 15 November 2012

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Stem Cell Biology Seminar Summary: Stem Cell Therapy for Human Neurodegenerative Disorders (2004)

Summary of "Stem cell therapy for human neurodegenerative disorders - how to make it work" Satya Yerrabolu Parkinson's Disease Viability Characterized by the degeneration of dopaminergic neurons
Stem cell grafts have been shown to normalize dopamine release and become fully integrated into neuronal circuitries
A problem that can arise though is dyskinesias, which adversely affects motor function Background Foremost, a definitive cause for Parkinson's Disease has not been found yet; however, multiple theories exist
One theory focuses on Lewy bodies. Lewy bodies are abnormal conglomerations of proteins in nerve cells that can hinder the proper function of dopaminergic neurons, which are regularly associated with voluntary movement and behavior
Another theory focuses on calbindin, which is a protein that protects dopamine from toxins in the brain. The lack of calbindin in neurons is proposed as a possible contributor to Parkinson's Disease Stroke ALS and Huntington's Stem Cell Neurons in PD Stem cells can form dopaminergic neurons
Previous studies have shown that mouse and monkey ESCs and NSCs have formed dopaminergic-like neurons
Fetal mesencephalic grafts contain cells that are about 5-10% dopaminergic
The picture above summarizes a variety of processes in which stem cells may generate functional neuronal cells Lindball, O., Kokaia, Z., Martinez-Serrano, A. (2004) Stem cell therapy for human neurodegenerative disorder-how to make it work, Nature Medicine, 10, S42-S50. Results Embryonic stem cells can form dopaminergic neurons in a variety of ways (seen in the figure above)
Surgery-controlled trials were not very successful
Grafted cells did not survive and the secon resulted in degenerative changes. There was also a high chance of immune rejection
Other trials resulted in dskynesia (7-15% of grafts), which is a movement disorder caused by irregular amount of dopamine. Stem Cell Therapy Stem cell therapies for PD have to address a few key issues:
Dyskinesia suppression
Mobility improvements
Long-lasting survival
Grafts should become refined so that they can be close to the area of damage and fully repair the brain
Cancer formation needs to be avoided
iPs cells?
Could remove the issue of immune rejection
Stroke and ESCs The blockage of an artery leads to focal ischemia in a CNS region in stroke
Different neurons and glial cells degenerate
Studies showed that grafts corresponded with an increase in metabolic activity and were successful Stem Cell Neurons Neurons were generated; however, they did not survive for a very long time
The addition of FGF-2, EGF, stem cell factor, caspase inhibitors, and anti-inflammatory drugs has been shown to increase the lifespan of newly-formed neurons Stem Cell Therapy Only a small amount of neurons and associated circuitries occurs after ESC treatment
To deal with this, developmental mechanisms must be explored to ensure that SCs will differentiate into fully functional cells
Transplantation may have to be coupled with stimulation of neurogenesis from endogenous NSCs ALS and ESCs ALS is characterized by progressive dysfunction and degeneration of motor neurons in the cerebral cortex, brain stem, and spinal cord
ESCs must target both upper and lower motor neurons
ESC grafts have shown slight beneficial effects in mice, but they were probably not caused by neuronal differentiation
A lot of research still needs to be performed Huntington's and ESCs Characterized by chorea and dementia
Grafts have generated sufficient reconstruction of circuitries
Extent of clinical benefit from these trials was not determined
Future therapies will have to ensure longer survival of grafted cells
Full transcript